| EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies M Ramos-Casals, P Brito-Zerón, S Bombardieri, H Bootsma, S De Vita, ... Annals of the rheumatic diseases 79 (1), 3-18, 2020 | 449 | 2020 |
| How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project) P Brito-Zerón, N Acar-Denizli, WF Ng, M Zeher, A Rasmussen, T Mandl, ... Clinical and experimental rheumatology 36 (3), S102-S112, 2018 | 175 | 2018 |
| Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients S Retamozo, N Acar-Denizli, A Rasmussen, IF Horváth, C Baldini, R Priori, ... Clinical and experimental rheumatology 37 (3 (S118)), 97-106, 2019 | 82 | 2019 |
| Epidemiological profile and north–south gradient driving baseline systemic involvement of primary Sjögren’s syndrome P Brito-Zerón, N Acar-Denizli, WF Ng, IF Horvath, A Rasmussen, R Seror, ... Rheumatology 59 (9), 2350-2359, 2020 | 73 | 2020 |
| Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study N Atas, B Armagan, E Bodakci, H Satis, A Sari, NSY Bilge, RB Salman, ... Rheumatology international 40 (1), 41-48, 2020 | 54 | 2020 |
| Comparing immunoglobulin A vasculitis (Henoch–Schönlein purpura) in children and adults: a single-centre study from Turkey ED Batu, A Sarı, A Erden, HE Sönmez, B Armağan, U Kalyoncu, ... Scandinavian Journal of Rheumatology 47 (6), 481-486, 2018 | 50 | 2018 |
| Rituximab experience in patients with long-standing systemic sclerosis–associated interstitial lung disease: a series of 14 patients A Sari, D Guven, B Armagan, A Erden, U Kalyoncu, O Karadag, SA Bilgen, ... JCR: Journal of Clinical Rheumatology 23 (8), 411-415, 2017 | 43 | 2017 |
| Comparing polyarteritis nodosa in children and adults: a single center study A Erden, ED Batu, HE Sönmez, A Sarı, B Armagan, ZS Arıcı, E Bilgin, ... International journal of rheumatic diseases 20 (8), 1016-1022, 2017 | 42 | 2017 |
| Childhood-onset of primary Sjögren’s syndrome: phenotypic characterization at diagnosis of 158 children M Ramos-Casals, N Acar-Denizli, A Vissink, P Brito-Zerón, X Li, F Carubbi, ... Rheumatology 60 (10), 4558-4567, 2021 | 39 | 2021 |
| Polyarteritis nodosa: lessons from 25 years of experience HE Sönmez, B Armağan, G Ayan, K Barut, ED Batu, A Erden, S Uğurlu, ... Clin Exp Rheumatol 37 (Suppl 117), 52-56, 2019 | 39 | 2019 |
| Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: single center real life results B Armagan, A Sari, A Erden, L Kilic, EC Erdat, S Kilickap, S Kiraz, ... Medicine 97 (13), e9930, 2018 | 32 | 2018 |
| Predictors of persistent inflammation in familial Mediterranean fever and association with damage H Babaoglu, B Armagan, E Bodakci, H Satis, N Atas, A Sari, ... Rheumatology 60 (1), 333-339, 2021 | 29 | 2021 |
| Pulmonary hypertension in Takayasu arteritis A Sari, YZ Sener, E Firat, B Armagan, A Erden, M Oksul, V Hekimsoy, ... International Journal of Rheumatic Diseases 21 (8), 1634-1639, 2018 | 28 | 2018 |
| Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever? A Erden, ED Batu, A Sarı, HE Sönmez, B Armagan, S Demir, E Fırat, ... Clin Exp Rheumatol, 2018 | 27 | 2018 |
| Proposal for a simple algorithm to differentiate adult-onset Still’s disease with other fever of unknown origin causes: a longitudinal prospective study E Bilgin, M Hayran, A Erden, B Armağan, A Sarı, L Kılıç, A Akdoğan, ... Clinical Rheumatology 38, 1699-1706, 2019 | 25* | 2019 |
| Thu0628 immune-related adverse events induced by cancer immunotherapies. Big data analysis of 13,051 cases (Immunocancer international registry) M Ramos-Casals, O Lambotte, M Kostine, L Calabrese, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 607-608, 2019 | 24 | 2019 |
| Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies G Hernández-Molina, B Kostov, P Brito-Zerón, A Vissink, T Mandl, ... Rheumatology 62 (1), 243-255, 2023 | 21 | 2023 |
| Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases P Brito-Zerón, SG Pasoto, A Robles-Marhuenda, T Mandl, A Vissink, ... Clinical and Experimental Rheumatology 38 (4), S95-S102, 2020 | 21 | 2020 |
| A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts O Karadag, A Erden, Y Bilginer, S Gopaluni, A Sari, B Armagan, I Ertenli, ... Rheumatology International 38 (10), 1833-1840, 2018 | 21 | 2018 |
| SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients P Brito-Zerón, S Melchor, R Seror, R Priori, R Solans, B Kostov, C Baldini, ... Rheumatology 60 (6), 2946-2957, 2021 | 20 | 2021 |
Abdulsamet ErdenDivision of Rheumatology, Department of Internal Medicine, Gazi UniversityVerified email at gazi.edu.tr
